- Home
- JBI vs BCRX Comparison
JBI vs BCRX Comparison
Compare JBI & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JBI
- BCRX
- Stock Information
- Founded
- JBI 2002
- BCRX 1986
- Country
- JBI United States
- BCRX United States
- Employees
- JBI N/A
- BCRX N/A
- Industry
- JBI Building Products
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- JBI Industrials
- BCRX Health Care
- Exchange
- JBI Nasdaq
- BCRX Nasdaq
- Market Cap
- JBI 1.5B
- BCRX 1.6B
- IPO Year
- JBI N/A
- BCRX 1994
- Fundamental
- Price
- JBI $7.66
- BCRX $7.51
- Analyst Decision
- JBI Buy
- BCRX Strong Buy
- Analyst Count
- JBI 5
- BCRX 5
- Target Price
- JBI $10.25
- BCRX $15.60
- AVG Volume (30 Days)
- JBI 1.6M
- BCRX 2.0M
- Earning Date
- JBI 10-29-2024
- BCRX 11-04-2024
- Dividend Yield
- JBI N/A
- BCRX N/A
- EPS Growth
- JBI N/A
- BCRX N/A
- EPS
- JBI 0.72
- BCRX N/A
- Revenue
- JBI $996,800,000.00
- BCRX $412,579,000.00
- Revenue This Year
- JBI N/A
- BCRX $38.01
- Revenue Next Year
- JBI N/A
- BCRX $19.04
- P/E Ratio
- JBI $10.59
- BCRX N/A
- Revenue Growth
- JBI N/A
- BCRX 29.92
- 52 Week Low
- JBI $6.68
- BCRX $4.03
- 52 Week High
- JBI $15.86
- BCRX $8.88
- Technical
- Relative Strength Index (RSI)
- JBI 44.97
- BCRX 45.56
- Support Level
- JBI $7.30
- BCRX $7.15
- Resistance Level
- JBI $8.10
- BCRX $7.62
- Average True Range (ATR)
- JBI 0.29
- BCRX 0.34
- MACD
- JBI 0.04
- BCRX -0.02
- Stochastic Oscillator
- JBI 28.12
- BCRX 22.86
About JBI Janus International Group Inc.
Janus International Group Inc is a manufacturer and supplier of turnkey solutions for self-storage, commercial, and industrial building Solutions. The company provides products that include roll-up and swing doors, hallway systems, relocatable storage MASS (Moveable Additional Storage Structures) units, and technologies for automating facility and door operation. It is operated through two geographic regions; Janus North America and Janus International. . The Janus International segment is comprised of Janus International Europe Holdings Ltd whose production and sales are largely in Europe and Australia. The Janus North America segment is comprised of all the other entities including Janus Core together with each of its operating subsidiaries, Betco, Inc.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.